Genetic Analysis of Signaling Components in Innate Immunity
Genetic Analysis of Signaling Components in Innate Immunity
批准号:
7670122
负责人:
David E Levy
金额:
$23.94万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-02-28
关键词:
AdjuvantAntiviral AgentsAntiviral resistanceAreaAttenuatedBiochemicalCell LineCellsChikungunya virusCollaborationsCritical PathwaysCytoplasmDataDendritic CellsDevelopmentDiagnosticEffectivenessElementsEquilibriumGene ExpressionGeneticHumanImmuneImmune systemImmunityImpairmentInfectionInfluenzaInfluenza A virusInterferon InducersInterferon Type IInterferonsKnowledgeLesionMediatingMissionMolecularMusNatural ImmunityNatureNucleic AcidsOutcomePathogenesisPathway interactionsProteinsResearchSignal PathwaySignal TransductionStagingSystemToll-like receptorsVaccinesVacciniaVaccinia virusViralVirulenceVirulence FactorsVirusVirus DiseasesVirus InhibitorsWorkbasebiodefensedrug discoverygene inductiongenetic analysisimmune resistanceinhibitor/antagonistmembermicrobialnovel strategiesnovel therapeuticspressurereceptorresponsesmall moleculetherapeutic targetviral resistance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Type I interferon (IFN) provides an initial component of innate immune resistance to viral infection and replication
by inducing a large set of antiviral effector proteins capable of inhibiting diverse viruses at multiple points in the
infection. Inherent to the effectiveness of this response are cellular signaling pathways that first trigger IFN gene
induction in response to infection and subsequently trigger IFN-stimulated gene (ISG) expression in response to
secreted IFN. IFN gene induction proceeds through two distinct pathways, a cytosolic signaling system triggered by
viral nucleic acid in the cytoplasm that operates in most infected cells and a transmembrane pathway dependent on
Toll-like receptor (TLR) proteins that is critical in dendritic cells. The essential nature of the IFN system in antiviral
immunity has been demonstrated by genetic and biochemical data, but its ultimate effectiveness is limited by viral
evasion through the action of viral virulence factors that impaire IFN action. The underlying hypothesis of our proposed
research is that through better understaning the molecular mechanisms of IFN induction and action and their
impairment by viral evasion, we will be able to devise novel therapeutics based on augmenting innate immunity and
inhibiting viral evasion. This project focuses on three distinct viruses that each impair the IFN pathway, influenza A
virus, vaccinia virus, and chikungunya virus; will analyze the interaction between viruses and IFN signaling in a unique
set of genetically modified dendritic cells lines; and will develop a platform to screen for small molecule inhibitors of viral
virulence. This work will be performed in close collaboration with other members of the innate immunity team, Drs.
Easier, Garcia-Sastre, and Wu.
This project is well integrated into the mission of the RCE. Innate immunity has emerged as an essential
component of the key focus areas of the RCE, impacting on adaptive immunity and being critical for athe adjuvant
effects of vaccines; providing an important diagnostic indication of infection; and uncovering a novel approach to
therapeutics by targeting the interaction between the innate immune system and virulence factors. Knowledge gained in
these studies will also be applicable to microbial innate immunity that relies on similar mechani
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A chikungunya Viral Replicon as a Platform for Antiviral Therapeutics
-
批准号:8789899
-
项目类别:
-
资助金额:$29.91万
-
财政年份:2014
-
负责人:David E Levy
-
依托单位:
Acquisition of an X-Rad 320 Biological Irradiator
-
批准号:8703903
-
项目类别:
-
资助金额:$16.47万
-
财政年份:2014
-
负责人:David E Levy
-
依托单位:
Training Program in Molecular Oncology and Immunology
-
批准号:8761272
-
项目类别:
-
资助金额:$34.81万
-
财政年份:2013
-
负责人:David E Levy
-
依托单位:
A chikungunya Viral Replicon as a Platform for Antiviral Therapeutics
-
批准号:8302538
-
项目类别:
-
资助金额:$40.51万
-
财政年份:2011
-
负责人:David E Levy
-
依托单位:
LUNG INTERFERON IN INFLUENZA VIRUS INFECTION
-
批准号:6610320
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2002
-
负责人:David E Levy
-
依托单位:
NPM ALK mediated transformation of T lymphocytes
-
批准号:6991316
-
项目类别:
-
资助金额:$29.38万
-
财政年份:2001
-
负责人:David E Levy
-
依托单位:
LUNG INTERFERON IN INFLUENZA VIRUS INFECTION
-
批准号:6480396
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2001
-
负责人:David E Levy
-
依托单位:
NPM ALK mediated transformation of T lymphocytes
-
批准号:7197729
-
项目类别:
-
资助金额:$4.13万
-
财政年份:2001
-
负责人:David E Levy
-
依托单位:
FUNCTION OF IRF7 IN RESPONSE TO VIRUS INFECTION
-
批准号:6196084
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2000
-
负责人:David E Levy
-
依托单位:
FUNCTION OF IRF7 IN RESPONSE TO VIRUS INFECTION
-
批准号:6374366
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2000
-
负责人:David E Levy
-
依托单位:
FUNCTION OF IRF7 IN RESPONSE TO VIRUS INFECTION
-
批准号:6632066
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2000
-
负责人:David E Levy
-
依托单位:
FUNCTION OF IRF7 IN RESPONSE TO VIRUS INFECTION
-
批准号:6510944
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2000
-
负责人:David E Levy
-
依托单位:
LUNG INTERFERON IN INFLUENZA VIRUS INFECTION
-
批准号:6331755
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2000
-
负责人:David E Levy
-
依托单位:
FUNCTION OF IRF7 IN RESPONSE TO VIRUS INFECTION
-
批准号:6747613
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2000
-
负责人:David E Levy
-
依托单位:
ISGF3 TRANSCRIPTION FACTOR FAMILY IN CYTOKINE SIGNALING
-
批准号:2064718
-
项目类别:
-
资助金额:$31.76万
-
财政年份:1990
-
负责人:David E Levy
-
依托单位:
SIGNAL TRANSDUCTION PATHWAY IN IFN INDUCED TRANSCRIPTION
-
批准号:3143552
-
项目类别:
-
资助金额:$18.14万
-
财政年份:1990
-
负责人:David E Levy
-
依托单位:
ISGF3 TRANSCRIPTION FACTOR FAMILY IN CYTOKINE SIGNALING
-
批准号:6045323
-
项目类别:
-
资助金额:$43.62万
-
财政年份:1990
-
负责人:David E Levy
-
依托单位:
ISGF3 TRANSCRIPTION FACTOR FAMILY IN CYTOKINE SIGNALING
-
批准号:2633500
-
项目类别:
-
资助金额:$35.73万
-
财政年份:1990
-
负责人:David E Levy
-
依托单位:
ISGF3 TRANSCRIPTION FACTOR FAMILY IN CYTOKINE SIGNALING
-
批准号:6626483
-
项目类别:
-
资助金额:$55.7万
-
财政年份:1990
-
负责人:David E Levy
-
依托单位:
ISGF3 Transcription Factor Family in Cytokine Signaling
-
批准号:7758248
-
项目类别:
-
资助金额:$61.52万
-
财政年份:1990
-
负责人:David E Levy
-
依托单位:
海外基金